← Journal search
JOURNAL PROFILE
Download details (PDF) ↓

Molecular Biomedicine (ISSN 2662-8651) is an open-access journal published by Springer Nature in Switzerland. It covers Biochemistry, Genetics and Molecular Biology, Molecular Biology and Molecular Medicine. It is indexed in Scopus, Web of Science, PubMed, DOAJ and HEC. Recorded metrics: impact factor 13, Scopus Q1, Web of Science Q1, CiteScore 11.7 and HEC X-Category. Article processing charge: USD 2,690. This profile brings together the journal's ISSN, publisher, country, subject area, HEC category, Scopus data, SJR and SCImago rank, Web of Science data, impact factor, indexing, open access status, APC, waiver policy, time to publication, aims and scope, about the journal, author instructions, journal website and registration details from the most reputable indexes, in one place.

Journal title

Molecular Biomedicine

ISSN
2662-8651
Subject area
BiochemistryGenetics and Molecular BiologyMolecular BiologyMolecular Medicine
Indexed
ScopusWeb of SciencePubMedDOAJHEC
Scopus Quartile
Q1
WoS Quartile
Q1
Impact Factor
13
Country
Switzerland
Publisher
Springer Nature
SJR
2.99
Open access
Yes
APC (USD)
2690
About the journal
Molecular Biomedicine is a fully open-access journal published by Springer (Switzerland). It has published all content under an open licence (CC BY) since 2020. Topics: biomedicine, genetics, bioinformatics, molecular biology, gene editing.
Aims and Scope
Molecular Biomedicine is a peer-reviewed, multidisciplinary journal focused on research that advances understanding of disease mechanisms and develops innovative approaches to diagnosis and treatment. It considers basic, translational, and clinical work, including studies in epigenetics, genomics, proteomics, gene editing, RNA biology, cell and gene therapies, immunotherapy, molecular imaging, and regenerative medicine. The journal publishes original research, reviews, letters, and research highlights.
Journal Website
Journal Website Direct Link ↗
Instructions for Authors URL
Journal's Author Direct Link ↗
Scopus URL
Scopus Direct Link ↗
APC Information URL
APC Information Direct Link ↗
WoS URL
Web of Science Direct Link ↗
SCImago Ranking
715
HEC
X-Category
Registered In
2020
Average Time To Publication After Submission (In Weeks)
10
Waiver policy
Yes
Scopus Cite Score
11.7
WoS Status
Emerging Sources Citation Index (ESCI)

Record last updated . Check current status at HEC HJRS, Scopus and the Web of Science Master Journal List before submitting. About our data.

Quick answers about Molecular Biomedicine

Is Molecular Biomedicine HEC recognised?

Yes. The catalogue records Molecular Biomedicine in HEC category X of the HEC Journal Recognition System, where W is the highest and Y the lowest category. Confirm the current category on HEC's HJRS website before you submit.

Is Molecular Biomedicine indexed in Scopus?

Yes. Molecular Biomedicine is listed as Scopus-indexed, in quartile Q1, with a CiteScore of 11.7. Check its current status on the Scopus Sources page.

Is Molecular Biomedicine in Web of Science?

Yes. Molecular Biomedicine is listed as a Web of Science journal in the Emerging Sources Citation Index (ESCI), with Web of Science quartile Q1. Confirm on Clarivate's Master Journal List.

What is the impact factor of Molecular Biomedicine?

The recorded journal impact factor of Molecular Biomedicine is 13. Clarivate updates impact factors every year in Journal Citation Reports.

Is Molecular Biomedicine open access, and what does it charge?

Molecular Biomedicine is an open-access journal and its APC is USD 2,690. Fees change, so check the journal's website before you submit.

How long does Molecular Biomedicine take to publish?

The recorded average time from submission to publication is about 10 weeks. Individual papers can take longer, especially when revisions are requested.

Who publishes Molecular Biomedicine?

Molecular Biomedicine is published by Springer Nature in Switzerland, under ISSN 2662-8651.

Research profile

Main research topics: Cancer Immunotherapy and Biomarkers, SARS-CoV-2 and COVID-19 Research, Epigenetics and DNA Methylation, Immunotherapy and Immune Responses, Cancer Cells and Metastasis, Cancer-related molecular mechanisms research.

Source: OpenAlex (CC0), retrieved 21 November 2026. Counts cover works OpenAlex has indexed and differ from Scopus and Web of Science.

Browse similar journals

Find Journal